Newleos Therapeutics News and Activities

Acquisition, funding and merger involving Newleos Therapeutics.

• Newleos Therapeutics has just announced a $93 Million fundraising (posted on February 19 2025).

View the org chart displaying its 17 main executives

Most searched biographies at Newleos Therapeutics

• Timothy Noyes, President and Chief Executive Officer
• Christoph Westphal, Co-Founder, Executive Chairman
• Ray Camahort, Director

Popular executive movements at Newleos Therapeutics

• Lea Hachigian, who was Vice President, Corporate Strategy and Operations, is promoted to Senior Vice President, Corporate Strategy and Operations  (posted on February 12 2026).
• Timothy Noyes has joined the company as President and Chief Executive Officer  (posted on October 21 2025).

Create your alert
to follow the executive moves at Newleos Therapeutics.

Newleos Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Newleos Therapeutics

Social media about Newleos Therapeutics

• Newleos Therapeutics on Wikipedia, Google News & Yahoo Finance
• Newleos Therapeutics on LinkedIn, X (Twitter) & YouTube